Is BIORQ or SPHD a better dividend investment in 2026?

BIORQ currently yields 200000000.00% with a 5% 5-year dividend growth rate. SPHD yields 4.30% with 5% growth. The better choice depends on your goal: BIORQ offers higher current income.

What is the dividend yield difference between BIORQ and SPHD?

BIORQ has a forward dividend yield of 200000000.00% ($2.00/share annually). SPHD yields 4.30% ($2.14/share annually). The yield gap is 199999995.70 percentage points.

Home › Compare › BIORQ vs SPHD

BIORQ vs SPHD: Dividend Comparison 2026

BIORQ yields 200000000.00% · SPHD yields 4.30%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 BIORQ wins by $4.875657285131069e+59M in total portfolio value

INVESTMENT

TIME HORIZON10 years

BIORQ

● Live price

200000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.875657285131069e+59M

Annual income

$487,565,248,955,786,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00

Full BIORQ calculator →

SPHD

● Live price

4.30%

Share price

$49.61

Annual div

$2.14

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$26.5K

Annual income

$567.37

Full SPHD calculator →

Portfolio growth — BIORQ vs SPHD

📍 BIORQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	BIORQ	SPHD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, BIORQ + SPHD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

BIORQ pays

SPHD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BIORQ

Annual income on $10K today (after 15% tax)

$17,000,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$414,430,461,612,418,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

SPHD

Annual income on $10K today (after 15% tax)

$365.92/yr

After 10yr DRIP, annual income (after tax)

$482.26/yr

At 15% tax rate, BIORQ beats the other by $414,430,461,612,418,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BIORQ + SPHD for your $10,000?

BIORQ: 50%SPHD: 50%

100% SPHD50/50100% BIORQ

Portfolio after 10yr

$2.4378286425655345e+59M

Annual income

$243,782,624,477,893,130,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

100.00%

📊

Analyst Conviction Gap

Where Wall Street is split right now

BIORQ

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Altman Z

-109.2

Piotroski

4/9

SPHD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BIORQ buys

SPHD buys

No recent congressional trades found for BIORQ or SPHD in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricBIORQSPHD

Forward yield	200000000.00% ✓	4.30%
Annual dividend / share	$2.00	$2.14 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$4.875657285131069e+59M	$26.5K ✓
Annual income after 10y	$487,565,248,955,786,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00 ✓	$567.37
Total dividends collected	$4.875656971401711e+59M	$5.0K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: BIORQ vs SPHD ($10,000, DRIP)

Year	BIORQ Portfolio	BIORQ Income/yr	SPHD Portfolio	SPHD Income/yr	Gap
1← crossover	$20,000,010,700	$20,000,000,000.00	$11,130	$430.50	+$20000.00M → BIORQ
2	$37,383,218,970,104,910	$37,383,197,570,093,464.00	$12,357	$447.82	+$37383218970.09M → BIORQ
3	$65,303,942,472,059,150,000,000	$65,303,902,472,014,860,000,000.00	$13,687	$464.65	+$65303942472059152.00M → BIORQ
4	$106,615,009,060,306,890,000,000,000,000	$106,614,939,185,088,440,000,000,000,000.00	$15,126	$480.98	+$1.0661500906030689e+23M → BIORQ
5	$162,672,273,967,082,950,000,000,000,000,000,000	$162,672,159,889,023,270,000,000,000,000,000,000.00	$16,682	$496.78	+$1.6267227396708296e+29M → BIORQ
6	$231,966,340,306,755,300,000,000,000,000,000,000,000,000	$231,966,166,247,422,140,000,000,000,000,000,000,000,000.00	$18,362	$512.03	+$2.319663403067553e+35M → BIORQ
7	$309,138,182,305,146,600,000,000,000,000,000,000,000,000,000,000	$309,137,934,101,162,400,000,000,000,000,000,000,000,000,000,000.00	$20,174	$526.72	+$3.091381823051466e+41M → BIORQ
8	$385,031,777,252,258,400,000,000,000,000,000,000,000,000,000,000,000,000	$385,031,446,474,403,340,000,000,000,000,000,000,000,000,000,000,000,000.00	$22,127	$540.84	+$3.850317772522584e+47M → BIORQ
9	$448,184,411,799,345,900,000,000,000,000,000,000,000,000,000,000,000,000,000,000	$448,183,999,815,344,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00	$24,230	$554.39	+$4.481844117993459e+53M → BIORQ
10	$487,565,728,513,106,900,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000	$487,565,248,955,786,300,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000,000.00	$26,493	$567.37	+$4.875657285131069e+59M → BIORQ

BIORQ vs SPHD: Complete Analysis 2026

BIORQ — Stock

Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. It is also developing diagnostics devices to help characterize the GI tract and diagnose GI diseases, such as small intestine bacterial overgrowth through the development of various technologies to diagnose at the site of the disease. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

Full BIORQ Calculator →

SPHD — ETF

The Invesco S&P 500 High Dividend Low Volatility ETF (Fund) is based on the S&P 500 Low Volatility High Dividend Index (Index). The Fund will invest at least 90% of its total assets in common stocks that comprise the Index. Standard & Poor's compiles, maintains and calculates the Index, which is composed of 50 securities traded on the S&P 500 Index that historically have provided high dividend yields and low volatility. The Fund and the Index are rebalanced and reconstituted semi-annually, in January and July.

Full SPHD Calculator →

📬

Get this BIORQ vs SPHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BIORQ vs SCHD BIORQ vs JEPI BIORQ vs O BIORQ vs KO BIORQ vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.